Pharmacokinetics- Absorption Lecture Notes PDF
Document Details
Uploaded by StunnedActinium
King Salman International University
2024
Dr. Asmaa Elsayyad
Tags
Summary
These lecture notes from King Salman International University cover the subject of drug absorption in veterinary medicine. The document examines factors related to the absorptive membrane, including nature and composition, and explores factors related to the drug, such as lipid solubility, pH, and molecular size. The notes also discuss various routes of administration and potential interactions.
Full Transcript
# Field of Veterinary Medicine ## Veterinary Medicine Program ### Lecture 3: General Pharmacology (Pharmacokinetics- Absorption) #### Dr. Asmaa Elsayyad Assistant Professor of Pharmacology 10/27/2024 Prepared By Dr. Asmaa Elsayyad Date: 27/10/2024 ## Terminology - Latent period: the time between...
# Field of Veterinary Medicine ## Veterinary Medicine Program ### Lecture 3: General Pharmacology (Pharmacokinetics- Absorption) #### Dr. Asmaa Elsayyad Assistant Professor of Pharmacology 10/27/2024 Prepared By Dr. Asmaa Elsayyad Date: 27/10/2024 ## Terminology - Latent period: the time between administration and the onset of action. - Duration of action: The time between the onset of action and elimination. - Half life (t 1/2): The time during which the drug concentration in the blood is reduced to 50%. - Withdrawal time: The time between stopping of drug administration until the drug is eliminated from the body. - Drug residue: the amount of a drug/metabolites deposited in animal tissues or products following its use. - Bioavailability: the fraction of dose that enters the systemic circulation in a chemically unchanged form. ## First-pass hepatic effect (First-pass metabolism): - Def., The 1st partial metabolism of a drug in the liver before it reaches systemic circulation. - Oral drugs → absorbed from the intestine → liver (1st metabolism) → ↓drug bioavailability. - E.g., Propranolol (Inderal). - Clinical significance of first-pass metabolism: - ↑oral therapeutic dose. - Liver disease → ↓therapeutic dose than normal. ## Enterohepatic circulation (recycling): - The drug is metabolized in the liver (by conjugation) → bile excretion → intestine (deconjugation) → free drug → reabsorbed again (2ry absorption) → to liver (portal circulation) →excreted again. - E.g., Purgatives (e.g. Phenolphthalein). - E.g., NSAIDs (e.g., Phenylbutazone). - Clinical significance of Enterohepatic circulation : - Longer duration of drug action. - Decrease the initial therapeutic dose. ## A. Drug absorption Def. the process of drug transfer from the site of administration to the systemic circulation. ### Factors affecting drug absorption: #### 1. Factors related to the absorptive membrane: - Nature & composition. - Blood flow. - Surface area. - Contact time. - Pathological state of the membrane. #### 2. Factors related to the drug: - Lipid solubility. - pH & ionization. - Molecular size. - Solubility & form. - Route of administration. - Interaction with other medications. ### A. Factors related to the absorptive membrane: #### 1. Nature & composition of the cell membrane: - The cell membrane is formed from a central lipid sheet (hydrophobic) and two outer layers of protein (hydrophilic) with many minute pores in between. - The central phospholipid bilayer → passage of lipophilic drugs. - Water pores → passage of hydrophilic non-fat soluble drugs. #### 2. Blood flow - ↑blood supply → ↑ absorption. #### 3. Surface area - ↑surface area → ↑absorption #### 4. Contact time - ↑contact time → ↑absorption. #### 5. Pathological state of the membrane: - Inflammatory conditions of the GIT → variable drug absorption, due to: - Damage of intestinal villi → ↓surface area. - ↑permeability. - Impaired transporter function. - Changes in pH. ### B. Factors related to the drug: #### B.1. Degree of lipid solubility: - ↑lipid-soluble (non-ionized) drugs→ ↑easily & rapidly absorbed (through the lipid bilayer by diffusion). - ↑Water-soluble (ionized) drugs cannot pass through the lipid bilayer (they pass through membrane pores or by carriers). **Lipid: water partition coefficient:** - It is a measure of the degree of lipid solubility of the drug. - Calculated by: solubility in lipid/solubility in water. - High coefficient → ↑lipophilic → ↑cross cell membranes (e.g., Steroids). - Low coefficient → ↑hydrophilic → ↓cross cell membranes (e.g., Insulin). #### B.2. pH & ionization (polarity) of the drug: - ↑Non-ionized (lipid-sol) drugs → ↑easily cross cell membrane. - 个lonized (water-sol) drugs → ↓cross cell membrane. - The degree of drug ionization is determined by the pH of the medium: - Acidic drugs (e.g., Aspirin) – Not ionized in the acidic pH of the stomach → rapidly absorbed. - Alkaline drugs (e.g., Antacids) - Not ionized in the alkaline pH of intestine⇒ rapidly absorbed. - Alkaline drugs ionize in the acidic pH of the stomach → not absorbed in the intestine & vice versa. **Clinical significance:** treatment of drug toxicity. E.g., - Amphetamine+ Ammonium chloride → ttt of amphetamine toxicity. - Sulfonamides+ Na-bicarb → ttt of slufonamides toxicity #### 3. Molecular size: - ↓molecular size → ↑easily cross cell membrane. #### 4. Solubility & pharmaceutical form: - Gaseous form > aqueous solution > oily solution/suspension > solid form (capsule, tablet). #### 5. Route of administration: - Generally, parenteral route > Oral. - IV, inhalation, sublingual > IM > SC > oral > Rectal > Topical. #### 6. Interaction with other drugs & food: - Full/empty stomach → delay/fasten absorption. - Interactions e.g., - Milk/milk products → ↓tetracycline absorption (chelation). - Vit.C → ↑iron absorption, while tannic acid → ↓iron absorption. - Antacids (alkaline) → ↓ absorption of acidic drugs (ionization). ## Mechanisms of drug absorption | | A. Passive transport | B. Facilitated diffusion (carrier-mediated) | C. Active transport | D. Pinocytosis | |----------------------------|------------------------------|----------------------------------------------|---------------------|--------------------------------------------------------------| | **Drug** | Lipid-sol Non-ionized | Non-lipid soluble lonized | | Fat-/water- sol ↑M.wt or drug aggregates | | **Site** | Lipid bilayer | Lipid bilayer | | Pinocytotic vesicle | | **Conc gradient** | With | Against | With | With | | **Carrier** | - | + | + | - | | **ATP** | - | + | + | - | | **E.g.** | • Aspirin <br> • Diazepam | • Some vitamins (vit. B12) <br> • Some amino acids (L-dopa into brain) | • Iodine into thyroid.<br> • Catecholamines into neurons.<br> • Electrolytes (Na+ & K+).<br> • Iron. | • Polypeptides (insulin & Igs) | ## Simple Diffusion - Movement of particles from high to low concentration without a protein ## Passive, Facilitated and Active Transport - **Passive diffusion** : Down the gradient, No carrier involved, No energy used - **Facilitated diffusion**: Down the gradient, Carrier mediated, No energy used / needed - **Active transport**: Up the gradient, Carrier mediated, Energy dependant